TI
RXST icon

Trexquant Investment’s RxSight RXST Stock Holding History

Trexquant Investment’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
607,935
+470,948
+344% +$2.84M 0.02% 1015
2026
Q1 		$844K Buy
136,987
+99,004
+261% +$822K 0.01% 1288
2025
Q4 		$396K Sell
37,983
-73,324
-66% -$736K ﹤0.01% 1392
2025
Q3 		$1M Sell
111,307
-148,071
-57% -$1.3M 0.01% 1150
2025
Q2 		$3.37M Buy
259,378
+114,973
+80% +$1.73M 0.04% 688
2025
Q1 		$3.65M Buy
144,405
+87,989
+156% +$2.61M 0.04% 630
2024
Q4 		$1.94M Sell
56,416
-74,813
-57% -$3.37M 0.02% 872
2024
Q3 		$6.49M Buy
131,229
+31,667
+32% +$1.62M 0.08% 372
2024
Q2 		$5.99M Buy
99,562
+46,708
+88% +$2.67M 0.09% 350
2024
Q1 		$2.73M Buy
52,854
+22,655
+75% +$1.11M 0.05% 535
2023
Q4 		$1.22M Sell
30,199
-17,031
-36% -$500K 0.03% 755
2023
Q3 		$1.32M Buy
47,230
+21,401
+83% +$638K 0.03% 643
2023
Q2 		$744K Buy
+25,829
New +$575K 0.02% 855

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Trexquant Investment's RXST Position: Q2 2026 in Review

Trexquant Investment increased its RxSight (RXST) stake by 344% in Q2 2026, buying an estimated $2.84M and bringing the position to 607,935 shares worth $2.93M. The position accounts for 0.02% of the portfolio, ranked #1015.

Trexquant Investment first reported a position in RXST in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.49M in Q3 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Trexquant Investment held 607,935 shares of RxSight worth $2.93M as of Q2 2026.
  • Trexquant Investment bought 470,948 RxSight shares in Q2 2026, an estimated $2.84M.
  • RxSight made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1015 holding.
  • Trexquant Investment first reported a position in RxSight in Q2 2023 and has held it in 13 quarters since.
  • Trexquant Investment's RxSight position peaked at $6.49M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.